What are the relapse (flare‑up) rates for bipolar I disorder and major depressive disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Frequency of Mood Episode Relapses in Bipolar I Disorder and Major Depressive Disorder

Bipolar I disorder has a substantially more chronic and relapsing course than major depressive disorder, with patients symptomatic approximately 47% of all weeks during long-term follow-up, compared to the episodic nature of MDD where relapse rates depend heavily on treatment adherence and duration. 1

Bipolar I Disorder: Relapse Frequency and Course

Overall Symptomatic Burden

  • Patients with bipolar I disorder are symptomatic during approximately 46.6% of all weeks during long-term prospective follow-up (up to 20 years), indicating a highly chronic illness course. 1

  • The longitudinal course of bipolar I disorder is characterized by frequent fluctuations in weekly symptom severity and polarity, with a dimensional nature involving all levels of affective symptom severity. 1

Depressive vs. Manic Symptom Predominance

  • Depressive symptoms predominate over manic/hypomanic symptoms by a 3:1 ratio in bipolar I disorder, with patients experiencing depressive symptoms during a much larger proportion of their symptomatic time. 1

  • Although mania defines bipolar I disorder diagnostically, depressive episodes and symptoms dominate the longitudinal course and disproportionately account for morbidity and mortality. 2

Subsyndromal Symptoms

  • Minor and subsyndromal symptoms are three times more common than full syndromal episodes during the long-term course of bipolar I disorder. 1

  • Weeks with cycling/mixed polarity symptoms are more common in bipolar I compared to bipolar II disorder. 1

Relapse Risk After Discontinuation

  • Withdrawal of maintenance lithium therapy is associated with dramatically increased relapse risk, especially within the 6-month period following discontinuation. 3

  • More than 90% of adolescents who were noncompliant with lithium treatment relapsed, compared to 37.5% of those who were compliant, highlighting the critical importance of continuous treatment. 3

Major Depressive Disorder: Relapse Frequency and Course

Treatment Phases and Relapse Definitions

  • The treatment of MDD is characterized by three phases: acute (6-12 weeks), continuation (4-9 months), and maintenance (≥1 year). 4

  • Relapse is defined as the return of depressive symptoms during the acute or continuation phases (considered part of the same episode), whereas recurrence is defined as return of symptoms during the maintenance phase (considered a new, distinct episode). 4

Maintenance Therapy Duration and Relapse Prevention

  • Clinicians should continue treatment for 4-9 months after a satisfactory response in patients with a first episode of MDD. 4

  • For patients who have had 2 or more episodes of depression, an even longer duration of therapy may be beneficial, as recurrence risk increases with each subsequent episode. 4

  • The likelihood of dying by suicide in major depressive disorders is higher in the first year following hospital discharge, necessitating longer monitoring periods. 4

Key Differences in Course Between Bipolar I and MDD

Chronicity

  • Bipolar I disorder demonstrates a more continuously symptomatic course (47% of weeks) compared to the more episodic nature of MDD, where patients may achieve complete remission between episodes with appropriate treatment. 1

Symptom Complexity

  • Bipolar I patients experience more weeks of cycling/mixed polarity and hypomanic symptoms, creating a more complex symptomatic picture than the purely depressive course of MDD. 1

Treatment Response and Relapse

  • The course of bipolar I disorder remains chronic even with treatment, whereas MDD patients who achieve remission and continue maintenance therapy have substantially lower relapse rates. 1, 4

Clinical Implications for Monitoring

Bipolar I Disorder

  • Maintenance therapy should continue for at least 12-24 months after mood stabilization; some individuals may need lifelong treatment when benefits outweigh risks. 3

  • Regular monitoring of symptoms, side effects, and laboratory parameters is essential throughout maintenance therapy. 3

Major Depressive Disorder

  • Clinicians should assess patient status, therapeutic response, and adverse effects on a regular basis beginning within 1-2 weeks of initiation of therapy. 4

  • Clinicians should modify treatment if the patient does not have an adequate response to pharmacotherapy within 6-8 weeks of initiation. 4

Common Pitfalls to Avoid

  • Inadequate duration of maintenance therapy in bipolar I disorder leads to relapse rates exceeding 90% in noncompliant patients, making premature discontinuation a critical error. 3

  • Failure to distinguish between relapse (same episode) and recurrence (new episode) in MDD can lead to inappropriate treatment duration decisions. 4

  • Overlooking the predominantly depressive nature of bipolar I disorder's longitudinal course may result in inadequate treatment of depressive symptoms. 2, 1

  • Antidepressant monotherapy in bipolar I disorder can trigger manic episodes or rapid cycling, representing a dangerous treatment error. 3

References

1
Research

Long-term symptomatic status of bipolar I vs. bipolar II disorders.

The international journal of neuropsychopharmacology, 2003

2
Research

Bipolar disorders.

Lancet (London, England), 2020

3
Guideline

First-Line Treatment of Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the typical frequency of flare‑ups (episodes) in working‑age adults with recurrent Major Depressive Disorder and Bipolar I disorder for FMLA documentation?
What medication is contraindicated in a patient with depressive symptoms and a history suggestive of potential bipolar disorder?
Can a patient with bipolar 2 (Bipolar II Disorder) also be diagnosed with Major Depressive Disorder (MDD)?
How do the cycling patterns differ between bipolar I disorder and bipolar II disorder?
What is the recommended treatment approach for a patient suspected of having bipolar disorder?
Is male pelvic floor therapy primarily for urinary incontinence, or does it also aim to restore bladder sensation and sexual function?
What are the most common presenting symptoms of type 1 diabetes mellitus?
How should I evaluate and manage an 82‑year‑old patient presenting with a new tingling sensation in the fingers?
What is the typical frequency of flare‑ups (episodes) in working‑age adults with recurrent Major Depressive Disorder and Bipolar I disorder for FMLA documentation?
Can a patient with atrial fibrillation who must temporarily discontinue a direct oral anticoagulant be bridged with low‑molecular‑weight heparin?
What is the appropriate management of a symptomatic pediatric typhoid fever carrier?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question